Omeros hits endpoint in pivotal stem cell transplant study by Nick Paul Taylor Wednesday, December 4, 2019 Omeros expects to use the data to win FDA approval, although secrecy around the design of the trial means there remains scope for skepticism.
Orchard Therapeutics hires ex-PTC exec Rothera as new CEO by Ben Adams Thursday, August 10, 2017 A 2016 Fierce 15 winner Orchard Therapeutics has taken on Mark Rothera as its new president and chief.
